COPD clinical trials in Indiana
11 studies for COPD are looking for participants at sites in Indiana.
Cities in Indiana
Ensifentrine (MK-5884) Study for the Prevention of Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in Adults With a History of Moderate or Severe Exacerbations While Receiving Standard of Care (SOC) (MK-5884-031/RPL554/ENHANCE-3)
- Velocity Clinical Research ( Site 4464), Valparaiso
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Nov 6, 2026 · NCT07874815A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Indiana University Health University Hospital, Indianapolis
- IU Health Ball Memorial Hospital, Inc., Muncie
RecruitingPhase 2
Ages 40 to 75 · All sexes · Updated Nov 5, 2026 · NCT07759245To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- DM Clinical Research-Indianapolis, Indianapolis
RecruitingPhase 2
Ages 40 to 85 · All sexes · Updated Oct 28, 2026 · NCT07684820Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Asha Clinical Research - Munster- Site Number : 8400115, Hammond
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Oct 23, 2026 · NCT07190222A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- ASHA Clinical Research - Munster, LLC, Hammond
- Methodist Hospital Southlake, Merrillville
RecruitingPhase 2/3
Ages 35 to 80 · All sexes · Updated Oct 22, 2026 · NCT07363694Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Indy Clinical Research- Site Number : 8400071, Indianapolis
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Oct 19, 2026 · NCT07190209The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry
- IU Health Pulmonology & Critical Care Medicine, Indianapolis
RecruitingObservational study
Ages 40 and older · All sexes · Updated Oct 15, 2026 · NCT07612878A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Evansville
- Research Site, Indianapolis
- Research Site, Indianapolis
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Oct 9, 2026 · NCT06878261Acoustic Waveform Respiratory Evaluation
- Indiana University, Indianapolis
RecruitingHealthy volunteers welcome
Ages 8 to 70 · All sexes · Updated Oct 5, 2026 · NCT06512064A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Valparaiso
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Oct 2, 2026 · NCT06283966A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Munster
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Sep 3, 2026 · NCT06883305From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.